Prostaglandin E2 promotes degranulation-independent release of MCP-1 from mast cells

Takayuki Nakayama1, Noriko Mutsuga, Lei Yao

  • 1Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892, USA. Nakayamt@mail.nih.gov

Insights

Prostaglandin E2 (PGE2) triggers mast cells to release monocyte chemoattractant protein-1 (MCP-1), a key factor in inflammation-associated angiogenesis. This release occurs rapidly without degranulation, highlighting a novel pathway in vascular changes during inflammation.

Area of Science:

  • Immunology
  • Cell Biology
  • Angiogenesis Research

Background:

  • Mast cells (MCs) are integral to inflammatory responses and contribute proangiogenic factors.
  • Vascular changes frequently accompany inflammation, yet the regulation of MC-derived proangiogenic factors remains unclear.

Purpose of the Study:

  • To investigate the impact of the inflammatory mediator prostaglandin E2 (PGE2) on the expression and release of proangiogenic factors from mast cells.

Main Methods:

  • Primary mast cells were exposed to varying concentrations of PGE2.
  • Monocyte chemoattractant protein-1 (MCP-1) release was quantified over time.
  • Immunoelectron microscopy was used to localize MCP-1 within mast cells.
  • The effects of dexamethasone, cyclosporine A, and PGE2 receptor subtype agonists were assessed.

Main Results:

  • PGE2 dose-dependently induced MCP-1 release from mast cells, with significant levels observed within 2 hours.
  • MCP-1 release was independent of mast cell degranulation or increased MCP-1 gene expression.
  • Immunoelectron microscopy revealed MCP-1 localized in the cytoplasm, separate from secretory granules.
  • Dexamethasone and cyclosporine A inhibited PGE2-induced MCP-1 secretion by approximately 60%.
  • EP1 and EP3 prostaglandin E2 receptor subtypes were identified as mediators of MCP-1 release.

Conclusions:

  • PGE2-induced MCP-1 release from mast cells represents a significant pathway contributing to inflammation-associated angiogenesis.
  • This mechanism expands the understanding of prostaglandin E2's biological activities and its role in inflammatory vascular remodeling.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...